Development of the Renal Glucose Reabsorption Inhibitors: A New Mechanism for the Pharmacotherapy of Diabetes Mellitus Type 2

作者：William N. Washburn · 发表于：Journal of Medicinal Chemistry · 年份：2009 · DOI：10.1021/jm8013019 · 被引用次数：157 · 研究领域：Diabetes Treatment and Management、Pharmacology and Obesity Treatment、Diabetes Management and Research

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTDevelopment of the Renal Glucose Reabsorption Inhibitors: A New Mechanism for the Pharmacotherapy of Diabetes Mellitus Type 2William N. Washburn†View Author Information Metabolic Diseases Chemistry, Research and Development, Bristol-Myers Squibb Co., P.O. Box 5400, Princeton, New Jersey 08543† Phone: 609-818-4971. Fax: 609-818-3550. E-mail: [email protected]Cite this: J. Med. Chem. 2009, 52, 7, 1785–1794Publication Date (Web):February 25, 2009Publication History Received15 October 2008Published online25 February 2009Published inissue 9 April 2009https://pubs.acs.org/doi/10.1021/jm8013019https://doi.org/10.1021/jm8013019review-articleACS PublicationsCopyright © 2009 American Chemical SocietyRequest reuse permissionsArticle Views5525Altmetric-Citations132LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given artic...